Elisa Maldonado-Holmertz, with 25 years \experience in multinational biopharma and medical device industries at Pharmaco (now PPD), Pharmacia & Upjohn (now Pfizer), Aerocrine, Emergo Group. Leadership roles in both emerging and established markets (USA, Belgium, Sweden, P.R. China) spanning an array of indications and responsibilities.
Elisa is also an advisor to TeVido BioDevices; a biotechnology company using 3D bio-printing to build custom grafts for breast cancer reconstruction. In addition to her industry background, she has graduate work in Business Management and Health Economics.
Elisa has several authorships and acknowledgments, including FDA Scientific Reports. Additionally, she has provided numerous presentations at CincyTech, Informa, InnoTech, Freescale Technology Forum, Plexus, Design Med, and RAPS Convergence to name a few, covering such topics as Medical Mobile Apps, Clinical Data Requirements, European Reimbursement, and US and Chinese Regulations. Her rounded experience in Clinical Research, Regulatory & Quality Affairs, Reimbursement and Market Access, Healthcare/Medical Writing, Marketing and Sales are of value to life science clients. Elisa left her VP position at Emergo Group to create Obelix Healthcare & Biotech Consultancy servicing the specific needs of large companies and start-ups in order to reach their commercial goals.